Health
United States
United States
New mRNA vaccine could reduce the recurrence and spread of skin cancer
Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
Continue Reading on NPR Health
This article is aggregated from NPR Health. Click below to read the full story.
BBC Health